Papillary thyroid carcinoma is the growth of tumour masses in the thyroid parenchyma. These abnormal growths are irregular in shape and are solid or cystic. The condition typically occurs in patients who have been exposed to radiation and is quite a common type of thyroid cancer. If left untreated, it could spread into the lungs and bones, though reports of metastasis to distant body parts are quite rare. This condition is diagnosed with a fine-needle aspiration biopsy, where a nodule or part of it is removed and examined in a laboratory.
Even as early as the diagnostic phase, patients from countries where advanced medical care is not widely available can go to Singapore, Thailand, and Malaysia. These countries, which are now recognised as medical tourism hubs, attract thousands of medical travellers year after year. With this option, international patients can enjoy the following benefits:
Easy access to internationally trained and certified cancer care specialists who offer multi-modal cancer treatments including specialised oncological surgery, chemotherapy, and long-term thyroid replacement hormone therapy. Palliative and support care is also provided when needed.
World-class medical facilities and technology - Singapore, Malaysia, and Thailand have a thriving medical tourism industry mainly due to their enormous investment in improving their medical infrastructure and bringing modern technology home from Western countries.
Low cost - Compared to Western countries, treatment modalities for papillary thyroid carcinoma is significantly more affordable in Southeast Asia. Patients seeking treatment in the region typically just pay 25-50% of what they would spend in the United States or United Kingdom.